Namenda Buyers Want Cert. In Pay-For-Delay Fight
Drug buyers who claim that a slew of pharmaceutical companies conspired to keep a generic version of the brand name Alzheimer's drug Namenda off the market are asking a New York...To view the full article, register now.
Already a subscriber? Click here to view full article